The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/31208
StudyName: Eligibility Non-small-cell Lung Cancer NCT00749567
Date of export from the portal: 02.07.2020
Copyright Holder: See clinicaltrials.gov
Date of Upload / last change: 29.07.2018
License: Creative Commons BY 4.0

----

Description: 
Combination of Erlotinib and Bevacizumab as Second-line Treatment in Patients With Non-small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00749567
